Sign in
Taking people in United StatesPhase 2

Hyperbaric Oxygen Brain Injury Treatment Trial

Key facts

Who runs it
Gaylan Rockswold
Where
Baltimore, Columbus, Detroit, Durham, Iowa City, Lexington, Minneapolis, Omaha, San Diego, and West Palm Beach, United StatesSee the 10 sitesAlso in 1 other country, 1 site
Trial code
Status
Recruiting
Phase
Phase 2
People taking part
200 people, planned
Started
25 Jun 2018
Expected to end
30 Jun 2029
Type of study
Interventional, 8 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Hyperbaric oxygen (1.5 ATA, no NBH)
  • Hyperbaric oxygen (2.0 ATA, no NBH)
  • Hyperbaric oxygen (2.5 ATA, no NBH)
  • Hyperbaric oxygen (1.5 ATA + NBH)
  • Hyperbaric oxygen (2.0 ATA + NBH)
  • Hyperbaric oxygen (2.5 ATA + NBH)
  • Normobaric Hyperoxia (NBH)
  • Usual Care
Record updated
2 June 2026

Who can take part

Age
16 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Age 16 years or older and 65 years or younger
  • Present with severe TBI, defined as Glasgow Coma Scale (GCS) of 3 to 8
  • Marshall computerized tomography (CT) score >1 in patients with a GCS of 7 or 8 or patients with an alcohol level >200 mg/dl
  • Ability to initiate the first hyperbaric oxygen treatment within 8 hours of admission in patients not requiring a craniotomy/craniectomy or any other major surgical procedure OR
  • Ability to initiate the first hyperbaric oxygen treatment within 14 hours of admission in patients requiring a craniotomy/craniectomy or major surgical procedure

Who cannot take part

  • Pre-existing neurologic disease (e.g. TBI or stroke or neurodegenerative disorder) with confounding residual neurologic deficits
  • First hyperbaric oxygen treatment cannot be initiated within 24 hours of injury
  • GCS of 3 with mid-position and non-reactive pupils bilaterally (4mm)
  • Penetrating head injury
  • Pregnant
  • Unstable acute spinal cord injury
  • Fixed coagulopathy
  • Severe hypoxia
  • Cardiopulmonary resuscitation performed
  • Coma suspected to de due to primarily non-TBI causes
  • Any contraindications to the study intervention

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 16 and 65 years old?

This trial is currently available in United States.

Also in 1 other country, 1 site

  • University of MarylandBaltimore, United StatesContact: Leslie SultTaking people
  • The Ohio State University -Wexner Medical CenterColumbus, United StatesContact: Gaylan L. Rockswold, M.D., Ph.D.No longer taking part
  • Detroit Receiving HospitalDetroit, United StatesContact: Nick WesnerTaking people
  • Duke University HospitalDurham, United StatesContact: Tammy HawleyTaking people
  • University of Iowa Hospitals and ClinicsIowa City, United StatesContact: Catherine FairfieldTaking people
  • University of Kentucky HospitalLexington, United StatesContact: Ronda A PETREYTaking people
  • Hennepin County HospitalMinneapolis, United StatesContact: Jessica GiesekeTaking people
  • University of Nebraska Medical CenterOmaha, United StatesContact: Gaylan L. Rockswold, M.D., Ph.D.No longer taking part
  • UCSD Medical Center - Hillcrest HospitalSan Diego, United StatesContact: Lilian Von HusenTaking people
  • St. Mary's Medical CenterWest Palm Beach, United StatesContact: Tracy RODRIGUEZTaking people

About the trial

What the trial wants to find out

The purpose of this innovative adaptive phase II trial design is to determine the optimal combination of hyperbaric oxygen treatment parameters that is most likely to demonstrate improvement in the outcome of severe TBI patients in a subsequent phase III trial.

The 8 groups in the trial

  • Hyperbaric oxygen (1.5 ATA, no NBH)Treatment being tested

    Hyperbaric oxygen at 1.5 ATA for 1 hour without NBH. This treatment is administered twice a day for 5 days.

  • Hyperbaric oxygen (2.0 ATA, no NBH)Treatment being tested

    Hyperbaric oxygen at 2.0 ATA for 1 hour without NBH. This treatment is administered twice a day for 5 days.

  • Hyperbaric oxygen (2.5 ATA, no NBH)Treatment being tested

    Hyperbaric oxygen at 2.5 ATA for 1 hour, without NBH. This treatment is administered twice a day for 5 days.

  • Hyperbaric oxygen (1.5 ATA + NBH)Treatment being tested

    Hyperbaric oxygen at 1.5 ATA for 1 hour and NBH for 3 hours. This treatment is administered twice a day for 5 days.

  • Hyperbaric oxygen (2.0 ATA + NBH)Treatment being tested

    Hyperbaric oxygen at 2.0 ATA for 1 hour and NBH for 3 hours. This treatment is administered twice a day for 5 days.

  • Hyperbaric oxygen (2.5 ATA + NBH)Treatment being tested

    Hyperbaric oxygen at 2.5 ATA for 1 hour and NBH for 3 hours. This treatment is administered twice a day for 5 days.

  • Normobaric Hyperoxia (NBH)Treatment being tested

    Normobaric Hyperoxia (NBH meaning 100% O2 at 1.0 ATA) for 4.5 hours twice a day for 5 days.

  • Usual careExisting treatment, for comparison

    Usual care for severe TBI

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial
Criteria questions
Built from NCT02407028, who can take part
Record updated
2 June 2026